Clinical Trials on Junctional Epidermolysis Bullosa in Ireland
Total 75 results
-
Amryt Research LimitedCompletedEpidermolysis BullosaUnited States, Spain, Israel, Australia, France, Denmark, Switzerland, Italy, Hong Kong, Argentina, Austria, Brazil, Chile, Colombia, Czechia, Georgia, Germany, Greece, Hungary, Ireland, Romania, Russian Federation, Serbia, Singapore, U... and more
-
NestléCompletedConstipation - FunctionalIreland
-
Société des Produits Nestlé (SPN)CompletedConstipation - FunctionalIreland
-
University College CorkUnknown
-
St. James's Hospital, IrelandUnknownBarrett Esophagus | Siewert Type II Adenocarcinoma of Esophagogastric Junction | Oesophagus Cancer | Siewert Type I Adenocarcinoma of Esophagogastric Junction | Siewert Type III Adenocarcinoma of Esophagogastric JunctionIreland
-
University College CorkScience Foundation Ireland; American Neurogastroenterology and Motility SocietyUnknown
-
VA Office of Research and DevelopmentVHA Geriatrics and Extended Care; US Department of Health and Human Services... and other collaboratorsCompletedCaregiving | Functional ImpairmentUnited States
-
PrecisionBiotics Group Ltd.Atlantia Food Clinical Trials Ltd.CompletedDepression, Anxiety | IBS - Irritable Bowel SyndromeIreland
-
DSM Nutritional Products, Inc.RecruitingIrritable Bowel Syndrome | IBS - Irritable Bowel SyndromeIreland
-
Regeneron PharmaceuticalsSanofiActive, not recruitingBullous PemphigoidUnited States, Japan, Germany, Australia, France, Israel, Poland, Spain, Taiwan
-
Cancer Trials IrelandSouthampton Clinical Trials Unit; Region H Rigshospitalet; Centre Hospitalier...CompletedOesophageal Cancer | Adenocarcinoma of the Oesophagus | Adenocarcinoma of the Oesophago-gastric Junction | Oesophageal Tumours | Junctional TumoursIreland, United Kingdom, Denmark, France, Sweden
-
National Institute of Neurological Disorders and...CompletedMovement DisordersUnited States
-
Brown UniversityAstraZenecaRecruitingEsophageal Cancer | Esophageal Adenocarcinoma | HER-2 Protein Overexpression | Gastroesophageal-junction CancerUnited States
-
Children's Cancer and Leukaemia GroupUnknownBrain and Central Nervous System Tumors | Cognitive/Functional Effects | Long-term Effects Secondary to Cancer Therapy in Children | Psychosocial Effects of Cancer and Its TreatmentUnited Kingdom, Ireland
-
AbbVieIronwood Pharmaceuticals, Inc.Enrolling by invitationIrritable Bowel Syndrome With Constipation | Functional ConstipationUnited States, Canada, Israel, Netherlands
-
Sucampo Pharma Americas, LLCTakedaCompletedConstipation - FunctionalUnited States, United Kingdom, Netherlands, Poland, Belgium, France, Canada
-
4D pharma plcCompletedIrritable Bowel SyndromeUnited States, United Kingdom, Ireland
-
Sucampo Pharma Americas, LLCSucampo AGCompletedConstipation - FunctionalUnited States, United Kingdom, Canada, Netherlands, Poland, Belgium, France
-
AbbVieIronwood Pharmaceuticals, Inc.Active, not recruitingIrritable Bowel Syndrome With Constipation | Functional ConstipationUnited States, Belgium, Bulgaria, Canada, Estonia, Israel, Italy, Netherlands, Poland, Puerto Rico, Spain, Ukraine, United Kingdom, Germany
-
Gulam ManjiMerck Sharp & Dohme LLCCompletedGastric Cancer | Adenocarcinoma of the Gastroesophageal JunctionUnited States
-
Rhode Island HospitalRecruitingCarpometacarpal Sprain | Thumb Sprain | Clostridium; BotulinumUnited States
-
Forest LaboratoriesIronwood Pharmaceuticals, Inc.CompletedFunctional Constipation in Children Ages 6-17 YearsUnited States, Canada
-
Bausch Health Americas, Inc.CompletedIrritable Bowel Syndrome | Colonic Diseases | Diarrhea | Gastrointestinal DiseaseUnited States
-
Prometheus LaboratoriesCompletedIrritable Bowel SyndromeUnited States
-
Bausch Health Americas, Inc.Completed
-
Bausch Health Americas, Inc.Completed
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingClinical Stage III Gastric Cancer AJCC v8 | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage IV Gastric Cancer AJCC v8 | Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 | Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction... and other conditionsUnited States, Puerto Rico
-
ArdelyxRecruitingIrritable Bowel Syndrome With Constipation (IBS-C)United States
-
Furiex Pharmaceuticals, IncCompletedIrritable Bowel SyndromeUnited States
-
Tioga PharmaceuticalsRTI Health SolutionsCompletedIrritable Bowel SyndromeUnited States
-
Ironwood Pharmaceuticals, Inc.Allergan Sales, LLCCompletedIrritable Bowel Syndrome Characterized by ConstipationUnited States
-
ArdelyxCompletedConstipation Predominant Irritable Bowel SyndromeUnited States
-
Bausch Health Americas, Inc.CompletedIrritable Bowel SyndromeUnited States
-
National Cancer Institute (NCI)SuspendedEsophageal Adenocarcinoma | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Gastroesophageal Junction Adenocarcinoma | Clinical Stage II Esophageal Adenocarcinoma AJCC v8 | Clinical Stage III Esophageal Adenocarcinoma AJCC v8 | Clinical Stage IVA Esophageal Adenocarcinoma... and other conditionsUnited States
-
ArdelyxCompletedConstipation Predominant Irritable Bowel SyndromeUnited States
-
Astellas Pharma Global Development, Inc.Active, not recruitingLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Korea, Republic of, China, Spain, Taiwan, Japan, Argentina, Canada, Croatia, Greece, Ireland, Malaysia, Netherlands, Portugal, Romania, Thailand, Turkey, United Kingdom
-
GlaxoSmithKlineCompletedIrritable ColonUnited States, Spain, South Africa, Sweden, Australia, Canada, Germany, United Kingdom, France, Netherlands
-
Ono Pharma USA IncCompletedIrritable Bowel Syndrome (IBS)United States
-
Lexicon PharmaceuticalsCompletedIrritable Bowel SyndromeUnited States
-
Forest LaboratoriesIronwood Pharmaceuticals, Inc.TerminatedIrritable Bowel Syndrome With ConstipationUnited States, Canada
-
Boston PharmaceuticalsCompletedDiarrhea-predominant Irritable Bowel SyndromeUnited States
-
GlaxoSmithKlineCompletedIrritable Bowel Syndrome (IBS) | Irritable ColonUnited States, Australia
-
Bausch Health Americas, Inc.CompletedIrritable Bowel Syndrome Characterized by ConstipationUnited States
-
Astellas Pharma Global Development, Inc.Active, not recruitingLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Spain, Taiwan, United Kingdom
-
AllerganCompletedIrritable Bowel Syndrome With DiarrheaUnited States, Canada
-
Furiex Pharmaceuticals, IncCompletedIrritable Bowel SyndromeUnited States, Canada, Puerto Rico, United Kingdom
-
Furiex Pharmaceuticals, IncCompletedIrritable Bowel SyndromeUnited States, Canada, United Kingdom
-
Bausch Health Americas, Inc.CompletedIrritable Bowel Syndrome Characterized by ConstipationUnited States
-
Hennepin Healthcare Research InstituteNational Health and Medical Research Council, Australia; National Cancer Institute... and other collaboratorsActive, not recruitingDepression | Stroke | Cancer | Bleeding | Dementia | Heart Disease | Functional DisabilityUnited States, Australia
-
Forest LaboratoriesIronwood Pharmaceuticals, Inc.CompletedIrritable Bowel Syndrome Characterized by ConstipationUnited States, Canada